WATAG Updates: Leadership, Medication Safety, and Health Reform Initiatives
This document outlines key updates presented at the CATAG meeting in Sydney on March 18, 2013. Gary Geelhoed assumes the role of WATAG Chairman, alongside new WADEP Executive Officers, including Rebecca Day and Rebecca Godfrey. Important administrative changes focus on high-cost drug evaluations for medicines like sugammadex and fampridine, alongside efforts to streamline PBS medicine listing. The report highlights initiatives for medication safety, antimicrobial stewardship, and improvements in clinical governance and electronic medication management to enhance healthcare delivery across Western Australia.
WATAG Updates: Leadership, Medication Safety, and Health Reform Initiatives
E N D
Presentation Transcript
WATAG Update Gary Geelhoed, WATAG Chairman David Lyon, WATAG Executive Officer Presented at the CATAG meeting, Sydney, 18th March 2013
New positions • WATAG and WAMSG Chairman • Gary Geelhoed • WADEP Executive Officers – from 0.4 to 1.0 FTE • Rebecca Day • Rebecca Godfrey from January 2013 • WAMSG Project Coordinator • Kathy Irwin from late March 2013 • Administrative changes
High-cost drug evaluations • sugammadex • rifaximin • fampridine • Process improvements • Streamlined hospital listing of PBS medicines • Strengthen relationships with hospital DTCs • Provision of IPA and MAP data • Improved access to i.Pharmacy data
Medication safety • NSQHS Standard 4 • High-risk medicines policy guidelines • Timely administration of medicines • Development of guidance and practical strategies (Working Group) • Closer link between WAMSG and Office of Safety and Quality
Antimicrobial stewardship • Establishment of a WA Antimicrobial Advisory Committee • Terms of reference and constitution • Membership • Project coordinator support • NSQHS Standard 3
On the radar • ABF / ABM and how it relates to medicines • WA statewide formulary – pre-approval • Health reforms – LHN and Medicare Locals • Electronic medication management • Clinical governance of medicines – system approach
